Enrollee Data Sample Clauses

Enrollee Data. Doctor agrees to comply with all requests by CMS, the North Dakota Office of the Commissioner of Insurance (“OCI”), the Minnesota Department of Health (“MDH”), or any other state agency or department that regulates Health Plan Companies, a health plan company and/or CCMI for information that CMS, OCI or MDH requires, the health plan company or CCMI intends to release to purchasers of health care coverage, enrollees and other consumers, including without limitation, CCMI-specific and Doctor-specific quality, outcomes and patient satisfaction data. Doctor consents to the release by health plan companies and CCMI of such information and agrees not to attempt to prohibit or restrict the release of such information. Doctor agrees to provide CCMI, a health plan company, OCI, MDH, and CMS all information necessary for the reporting and submission obligations to OCI, MDH or CMS, including, but not limited to: all data necessary to characterize the context and purposes of each encounter between an Enrollee and Doctor; patterns of utilization of Doctor’s services; the availability, accessibility and acceptability of Doctor’s services; changes in the health status of Enrollees; and other matters that CMS, OCI, or MDH may require. Doctor certifies that all Enrollee encounter data shall be accurate, complete and truthful.
Sample 1See All (4)
AutoNDA by SimpleDocs
Enrollee Data. The contractor shall maintain a complete history of enrollee information, including contractor enrollment, primary care provider assignment, third party liability coverage, and Medicare coverage. In addition, the contractor shall capture demographic information relating to the enrollee (age, sex, county, etc.), information related to family linkages, information relating to benefit and service limitations, and information related to health care for enrollees with special needs.
Sample 1Sample 2
Enrollee Data. Doctor agrees to comply with all requests by CMS, the Minnesota or other state department of health (“MDH”), a health plan company and/or CCMI for information that CMS or MDH requires, the health plan company or CCMI intends to release to purchasers of health care coverage, enrollees and other consumers, including without limitation, CCMI-specific and Doctor-specific quality, outcomes and patient satisfaction data. Doctor consents to the release by health plan companies and CCMI of such information and agrees not to attempt to prohibit or restrict the release of such information. Doctor agrees to provide CCMI, a health plan company, MDH, and CMS all information necessary for the reporting and submission obligations to MDH or CMS, including, but not limited to: all data necessary to characterize the context and purposes of each encounter between an Enrollee and Doctor; patterns of utilization of Doctor’s services; the availability, accessibility and acceptability of Doctor’s services; changes in the health status of Enrollees; and other matters that CMS or MDH may require. Doctor certifies that all Enrollee encounter data shall be accurate, complete and truthful.
Sample 1

Related to Enrollee Data

  • User Data In addition to any disclosures authorized by Section 24, You and Your Authorised Users consent and agree that the RIM Group of Companies may access, preserve, and disclose Your or Your Authorised Users' data, including personal information, contents of your communication or information about the use of Your BlackBerry Solution functionality and the services or software and hardware utilized in conjunction with Your BlackBerry Solution where available to RIM ("User Data"), to third parties, including foreign or domestic government entities, without providing notice to You or Your Authorized Users under the laws of countries where the RIM Group of Companies and its service providers, other partners and affiliates are located in order to: (i) comply with legal process or enforceable governmental request, or as otherwise required by law; (ii) cooperate with third parties in investigating acts in violation of this Agreement; or (iii) cooperate with system administrators at Internet service providers, networks or computing facilities in order to enforce this Agreement. You warrant that You have obtained all consents necessary under applicable law from Your Authorised Users to disclose User Data to the RIM Group of Companies and for the RIM Group of Companies to collect, use, process, transmit, and/or disclose such User Data as described above.

  • Customer Data 5.1 The Customer shall own all right, title and interest in and to all of the Customer Data and shall have sole responsibility for the legality, reliability, integrity, accuracy and quality of the Customer Data.

  • Client Data The Subrecipient shall maintain client data demonstrating client eligibility for services provided. Such data shall include, but not be limited to, client name, address, income level or other basis for determining eligibility, and description of service provided. Such information shall be made available to Grantee monitors or their designees for review upon request.

  • Interactive Data The interactive data in eXtensible Business Reporting Language included as an exhibit to the Registration Statement or incorporated by reference in the Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance with the Commission’s rules and guidelines applicable thereto.

  • Operations Manual The Franchisor agrees to loan to the Franchisee one or more manuals, technical bulletins, cookbooks and recipes and other written materials (collectively referred to as “Operations Manual”) covering Factory Candy ordering, Store Candy manufacturing, processing and stocking and other operating and in-store marketing techniques for the ROCKY MOUNTAIN CHOCOLATE FACTORY Store. The Franchisee agrees that it shall comply with the Operations Manual as an essential aspect of its obligations under this Agreement, that the Operations Manual shall be deemed to be incorporated herein by reference and failure by the Franchisee to substantially comply with the Operations Manual may be considered by the Franchisor to be a breach of this Agreement.

  • Medical Records Medical records relating to Trial Subjects that are not submitted to Sponsor may include some of the same information as is included in Trial Data; however, Sponsor makes no claim of ownership to those documents or the information they contain. c.

  • Customer Service A. PRIMARY ACCOUNT REPRESENTATIVE. Supplier will assign an Account Representative to Sourcewell for this Contract and must provide prompt notice to Sourcewell if that person is changed. The Account Representative will be responsible for: • Maintenance and management of this Contract; • Timely response to all Sourcewell and Participating Entity inquiries; and • Business reviews to Sourcewell and Participating Entities, if applicable.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, Registration Statement, the Pricing Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with applicable laws, rules, regulations and policies of the Food and Drug Administration of the U.S. Department of Health and Human Services (the “FDA”) or any committee thereof or of any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are materially inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Pricing Disclosure Package or the Prospectus; for such studies that have been or are being conducted, the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by foreign government or drug or medical device regulatory agencies, or foreign health care facility Institutional Review Boards; and no investigational new drug application filed by or on behalf of the Company or any of its subsidiaries with the FDA has been terminated or suspended by the FDA, and neither the FDA nor any applicable foreign regulatory agency has commenced, or, to the knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend, any proposed or ongoing studies conducted or proposed to be conducted by or on behalf of the Company or any of its subsidiaries.

Time is Money Join Law Insider Premium to draft better contracts faster.